Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
WGS
#2057
GeneDx Holdings Corp. - Class A Common Stock
62.3
6
USD
-0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.33%
Monthly Change
+1.96%
6 month change
-41.11%
Year Change
-24.27%
Previous Close
63.8
5
Open
60.7
9
Low
59.9
5
High
62.9
9
Volume
994
Markets
US Stock Market
Healthcare
Health Information Services
WGS
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
1.34 M
7.42 M
11.77 M
26.05 M
28.07 M
29.29 M
29.69 M
Valuation ratios
Enterprise value
—
—
—
23.6 M
2.13 B
3.75 B
1.96 B
Price to earnings ratio
—
—
—
-0.37
-39.62
-178.16
-24.76
Price to sales ratio
—
—
—
0.32
6.77
8.71
4.33
Price to cash flow ratio
—
—
—
-0.36
-72.53
111.94
-209.16
Price to book ratio
—
—
—
0.28
8.43
12.09
1.69
Enterprise value to EBITDA ratio
—
—
—
-0.15
-138.91
3 170.92
-29.36
Profitability ratios
Return on assets %
—
-0.44
-1.12
-0.42
-0.12
-0.04
-0.13
Return on equity %
—
-0.63
-2.16
-0.77
-0.21
-0.07
-0.25
Return on invested capital %
—
-648.97
-999.03
-224.02
-36.47
-16.96
-78.29
Gross margin %
—
-7.82
-11.4
44.19
63.64
69.74
66.71
Operating margin %
—
-210.25
-284.48
-88.67
-7.6
-3.06
-56.2
EBITDA margin %
—
-197.31
-269.16
-78.25
-5.01
0.28
-58.26
Net margin %
—
-115.64
-233.91
-86.3
-17.12
-4.92
-61.92
Liquidity ratios
Quick ratio
—
4.44
1.38
2.95
3.42
2.34
2.95
Current ratio
14.12
4.77
1.47
3.1
3.61
2.46
3.09
Inventory turnover
—
6.84
11.1
10.03
11.43
9.27
2.6
Asset turnover
—
0.43
0.45
0.45
0.73
0.82
0.2
Solvency ratios
Debt to assets ratio
—
0.02
0.01
0.13
0.12
0.09
0.19
Debt to equity ratio
—
0.03
0.02
0.23
0.21
0.16
0.38
Long term debt to total assets ratio
—
0.02
0.02
0.13
0.13
0.1
0.2
Long term debt to total equity ratio
—
0.03
0.04
0.25
0.23
0.18
0.39
Per share metrics
Operating cash flow per share
—
-58.15
-31.18
-7.41
-1.06
1.16
-0.31
EBIT per share
—
-134.5
-67.5
-7.37
-0.86
-0.68
-2.64
EBITDA per share
—
-127.84
-61.71
-6.56
-0.57
0.04
-2.29
Total debt per share
—
3.36
1.44
2.24
2
1.68
3.3
Cash per share
—
122.31
12.11
5.35
5.25
5.98
5.82
Net current asset value per share
—
147.64
20.77
7.5
7.36
9.37
9.23
Tangible book value per share
—
118.5
24.78
9.38
9.12
10.76
8.66
Working capital per share
—
116.72
6.67
5.08
5.32
5.56
6.24
Book value per share
—
118.5
24.78
9.38
9.12
10.76
8.66
News
GeneDx Stock: Why I Think The Selloff Went Too Far (NASDAQ:WGS)
Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update
GeneDx: Disappointing Q1 Creates Another Turnaround Opportunity (NASDAQ:WGS)
GeneDx: The 50% Crash Creates A Compelling Entry (NASDAQ:WGS)
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)
GeneDx Holdings Corp. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:WGS) 2026-05-06
The 'Alarming' Results That Caused GeneDx Stock To Plummet 50%
GeneDx Holdings Corp. (WGS) Q1 2026 Earnings Call Transcript
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates
Alger Small Cap Growth Fund Q1 2026 Portfolio Update
Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings?
Three Best Genomics Stocks for Your Portfolio in 2026